Disulfide bond
|
114
|
3.01 × 10−25
|
2.77
|
Transcription factor activity, sequence‐specific DNA binding
|
62
|
1.93 × 10−10
|
2.36
|
Homeobox
|
21
|
7.90 × 10−10
|
5.09
|
Immunoglobulin‐like fold
|
35
|
1.51 × 10−9
|
3.17
|
Extracellular matrix organization
|
25
|
1.83 × 10−9
|
4.13
|
Epidermal‐growth‐factor‐like domain
|
17
|
4.44 × 10−7
|
4.43
|
Protein digestion and absorption
|
11
|
1.32 × 10−6
|
6.72
|
Insulin‐like growth factor binding protein, N‐terminal
|
13
|
3.04 × 10−6
|
5.08
|
High mobility group (HMG) box domain
|
13
|
8.98 × 10−6
|
4.65
|
Integrin complex
|
6
|
3.10 × 10−4
|
8.31
|
Antiviral defense
|
29
|
8.83 × 10−23
|
11.31
|
Type I interferon signaling pathway
|
21
|
5.96 × 10−20
|
15.66
|
Innate immunity
|
25
|
1.68 × 10−13
|
6.6
|
Response to virus
|
16
|
3.93 × 10−9
|
7.01
|
2ʹ‐5ʹ‐Oligoadenylate synthetase activity
|
4
|
1.69 × 10−4
|
28.2
|
retinoic acid‐inducible gene I (RIG‐I)‐like receptor signaling pathway
|
8
|
9.57 × 10−4
|
4.88
|
Thiol protease
|
11
|
0.001573
|
3.33
|
Response to cytokine
|
8
|
0.003901
|
3.92
|
Mitophagy
|
6
|
0.004002
|
5.52
|
Nucleophagy
|
16
|
0.007451
|
2.14
|